Neuroendoscopy Global Market Report 2025

The neuroendoscopy market size has grown strongly in recent years. It will grow from $0.73 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to factors such as the growing preference for quicker recovery procedures, increased use of neuroendoscopy in pediatric neurosurgeries, technological advancements in endoscopic tools, heightened awareness among both patients and surgeons about the benefits of neuroendoscopy, and rising healthcare spending, along with improvements in hospital infrastructure.

The neuroendoscopy market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period is expected to be driven by the increasing use of robotics in neuroendoscopy, growing investments in neurosurgical research and development, a higher demand for personalized and targeted neurological treatments, greater adoption of advanced imaging technologies in endoscopy, and the expansion of specialized neurosurgery centers globally. Key trends in the forecast period include developments in high-definition and 3D neuroendoscopic systems, the advanced integration of artificial intelligence in neuroendoscopy, the creation of flexible and ultra-thin endoscopes for complex procedures, innovations in minimally invasive surgical methods, and improvements in disposable neuroendoscopy instruments.

The increasing incidence of brain tumors is expected to drive the growth of the neuroendoscopy market in the coming years. Brain tumors are abnormal cell growths within the brain or spinal canal, which can either be malignant or benign. These tumors can impact brain function and often require surgical, radiological, or medical treatments, depending on their type and location. The rise in brain tumor cases is linked to better diagnostic imaging and increased exposure to environmental risk factors, including ionizing radiation and industrial pollutants. Neuroendoscopy provides a minimally invasive method for treating brain tumors, enabling tumor removal or biopsy with reduced trauma, quicker recovery, and fewer complications. For example, in 2023, Cancer Australia reported approximately 1,924 new cases of brain cancer, making up 1.2% of all new cancer cases in the country. Thus, the growing number of brain tumor cases is contributing to the growth of the neuroendoscopy market.

Companies in the neuroendoscopy market are focusing on innovations such as the biportal endoscopic surgical system to improve surgical precision, reduce invasiveness, speed up recovery, and extend the scope of treatable neurological conditions. A biportal endoscopic system uses two entry points one for viewing and one for operating. This approach offers clearer imaging, more accurate procedures, and faster recovery times. For instance, in October 2023, Joimax, a US-based company, launched the iLESSYS biportal endoscopic system for spinal surgery, which enhances precision and freedom of movement through biportal access. The system features tools for triangulation, irrigation control, and tissue resection, supporting both biportal and bimanual techniques.

In August 2024, KARL STORZ, a German medical technology company, acquired Asensus Surgical Inc. for an undisclosed sum. This acquisition enhances KARL STORZ's capabilities in robotic surgery, enabling the provision of AI-driven, minimally invasive solutions that improve surgical precision and patient outcomes. Asensus Surgical Inc., based in the US, specializes in digital surgical technologies.

Major players in the neuroendoscopy market are Medtronic plc, Stryker Corporation, Schindler Endoskopie Technologie GmbH, Carl Zeiss Meditec AG, Karl Storz SE & Co. KG, Integra LifeSciences Holdings Corporation, Natus Medical Incorporated, Aesculap AG, Richard Wolf GmbH, Brainlab AG, B. Braun Melsungen AG, Clarus Medical LLC, ATMOS MedizinTechnik GmbH & Co. KG, NeuroOne Medical Technologies Corporation, Machida Endoscope Co. Ltd., Adeor Medical AG, Cliniva Healthcare, Inova Technology GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Tonglu WANHE Medical Instrument Co. Ltd.

North America was the largest region in the neuroendoscopy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroendoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroendoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neuroendoscopy is a minimally invasive surgical method used to diagnose and treat neurological conditions, including brain tumors, epilepsy, and cerebrovascular disorders. It involves using specialized endoscopic instruments inserted through small incisions, providing a less invasive option compared to traditional surgery. The main objective is to deliver precise treatment with minimal damage to surrounding tissues, which leads to faster recovery, reduced infection risks, and lower healthcare expenses. This technique enhances surgical accuracy, improves patient outcomes, and aligns with the growing trend toward minimally invasive approaches in neurosurgery.

The primary products in neuroendoscopy include rigid neuroendoscopes, rigid fiberscopes, rigid videoscopes, and flexible neuroendoscopes. Rigid neuroendoscopes are straight, inflexible instruments frequently used in brain surgeries. They provide high-resolution imaging via a lens system, allowing surgeons to clearly view internal brain structures. These instruments are used in procedures such as tumor removal and endoscopic third ventriculostomy (ETV) for both adult and pediatric patients. The procedures are typically carried out by various end users, such as hospitals, clinics, and clinical laboratories.

The neuroendoscopy market research report is one of a series of new reports that provides neuroendoscopy market statistics, including the neuroendoscopy industry global market size, regional shares, competitors with the neuroendoscopy market share, detailed neuroendoscopy market segments, market trends, and opportunities, and any further data you may need to thrive in the neuroendoscopy industry. This neuroendoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neuroendoscopy market consists of revenues earned by entities providing services such as minimally invasive neurosurgeries, diagnostic imaging, patient care, and post-operative recovery solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroendoscopy market also includes sales of advanced endoscopic equipment, surgical tools, diagnostic imaging systems, and specialized surgical instruments used in neurosurgery. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.